ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,236.76
1.06%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.872
0.00%
Brent Oil
82.845
1.06%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Capstone Therapeutics Corp (MM) (CAPS)

  7. Capstone Therapeutics Corp (MM) (CAPS) ニュース

CAPS

Capstone Therapeutics Corp (MM) (CAPS)

Capstone Therapeutics Corp (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CAPS
日付受信時刻ニュースソース見出しコード企業名
2018/05/0722 : 00GlobeNewswire Inc.LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, ChinaNASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/07/2019 : 03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/07/1907 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/07/1407 : 02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/07/0621 : 00GlobeNewswire Inc.Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; PulmonNASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/07/0605 : 51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/07/0203 : 12Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/3007 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/1806 : 22Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/1105 : 36Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/1002 : 21Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-A12B/A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/0901 : 42Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/0901 : 31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/0901 : 30GlobeNewswire Inc.Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on JuneNASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/0621 : 01Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/06/0103 : 00GlobeNewswire Inc.Capstone Therapeutics Signs Alliance With BiolineRx to Develop Chrysalin (TP508) in Acute Myocardial InfarctionNASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/05/2706 : 07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/05/2706 : 00GlobeNewswire Inc.Capstone Therapeutics Reminds Stockholders of Annual Meeting on June 6, 2011 and Encourages All Stockholders to VoteNASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/05/1322 : 00Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/05/1001 : 22Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/04/3004 : 12Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/04/2805 : 45Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/04/2805 : 45GlobeNewswire Inc.Capstone Therapeutics Confirms Early Signal of AZX100 Effect Based on Final Results of Phase 2a Pilot Clinical Trial in SurgicalNASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/04/0505 : 05GlobeNewswire Inc.Capstone Therapeutics Announces Update to Timing of Release of Final Results From AZX100 Phase 2a Pilot Clinical Trial in SurgicNASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/03/3003 : 37Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/03/2922 : 02Edgar (US Regulatory)Annual Report (10-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/02/1203 : 11Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/01/1903 : 21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/01/1903 : 08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
2011/01/1903 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
 Showing the most relevant articles for your search:NASDAQ:CAPS

最近閲覧した銘柄

DBI
I1SN
Xtr EUR Corporate Bond U...
GATE
SGBUSDT
Songbird
LBNK
BWOUSDT
Battle World
COIN
MINDSBTC
Minds
BIT
S29275
Societe Generale Effekten
NASDAQ
LKFN
Lakeland Financial
NASDAQ
PTAC
PropTech Acquisition
COIN
SIMUSD
USOTC
ORYYF
Oryx International Growth (PK)
NASDAQ
FOYAGX
Income Allocation Closed...
EU
5099T
5099T
ASX
SFC
Schaffer
COIN
SCOLEUR
Scolcoin
COIN
CHEXXUSD
Chintai Exchange Token
HITB
GRTUSD
Graph Token
TSX
5130
HiroHoldings
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有